VSIR and adenocarcinoma: In this study, we hypothesize that combining VISTA inhibition with RT will result in an enhanced T-cell-mediated apoptosis response and overall improved treatment efficacy in B16F10 melanoma and MC38 adenocarcinoma murine flank tumor models.